BP PLC
29 October 2002
press release
October 29, 2002
The following replaces the directorate change announcement released at 10.32 GMT
today, under reference 0616D. This version contains a fourth paragraph which
was lost during the original transmission to the stock exchange.
BP BOARD ANNOUNCEMENT
The board of BP p.l.c. announced today that it intends to appoint Dr Byron Grote
as chief financial officer (CFO) of the company with effect from November 21,
2002.
Dr Grote, 54, will succeed Dr John Buchanan, 59, who has been CFO since 1996. Dr
Buchanan is retiring from the board as of the same date.
BP chief executive Lord Browne said: 'I would like to express our appreciation
for the immense contribution John Buchanan has made to BP over a 33-year career,
in particular in his role as CFO over the last six years, a period of
unprecedented expansion for the company.'
Dr Grote was appointed an executive director of BP and chief executive of BP
Chemicals in August 2000. On his move to CFO he will retain his additional
board responsibilities for the Integrated Supply & Trading function and the Asia
region. His board responsibilities for Chemicals will be assumed by BP deputy
chief executive Rodney Chase. John Buchanan's board responsibilities for
Australasia will pass to Exploration chief executive Richard Olver.
- ENDS -
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.